| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Xiaosong Bai CEO | OTC PINK Exchange | HK0000311099 ISIN |
| Hong Kong Country | 72,764 Employees | 3 Jun 2026 Last Dividend | - Last Split | - IPO Date |
China Resources Pharmaceutical Group Limited, a significant player in the healthcare and pharmaceutical sectors, incorporates a comprehensive approach to its business by engaging in the research, development, manufacture, distribution, and retail of pharmaceutical and other healthcare products. Primarily operating in Mainland China and Hong Kong, the company functions through four main segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and Others. Originally known as China Resources Medications Group Limited, it rebranded to its current name in December 2011. Established in 2007 and headquartered in Wan Chai, Hong Kong, this subsidiary of CRH (Pharmaceutical) Limited has a broad operational scope, catering to various healthcare needs through its extensive product portfolio and services. It distinguishes itself through a potent mix of manufacturing, comprehensive distribution network, and retail capabilities, all aimed at improving healthcare accessibility and efficiency.
The company's offerings span across a wide array of healthcare needs, ensuring a comprehensive approach to wellbeing and medical care: